Advancing clinical trials for rare renal cell carcinoma subtypes: Consensus statements from the International Kidney Cancer Symposium North America 2025 think tank
Year: 2026
Type: article
Authors: Pavlos Msaouel, Salvatore La Rosa, Edwin Jason Abel, Laurence Albiges, Pedro C. Barata, Stephanie A. Berg, David A. Braun, James Brugarolas, Matthew T. Campbell, Marie I. Carlo, Katie Coleman, Nicholas G. Cost, Arighno Das, Arpita Desai, Nazli Dizman, Daniela Drago, Minas Economides, Daniel M. Geynisman, Meghan Griffith, Tasha Hall, Elizabeth P. Henske, Eric Jonasch, Prateek Khanna, Ritesh R. Kotecha, Amy Luckenbaugh, Jodi K. Maranchie, Viraj Master, Allison M. May, Robert J. Motzer, Moshe C. Ornstein, Michael V. Ortiz, Sumanta K. Pal, Jose R. Perez, Brian Rini, Daniel D. Shapiro, Brian M. Shuch, Adam E. Singer, Eric A. Singer, Walter M. Stadler, Michael Staehler, Nizar M. Tannir, Ulka N. Vaishampayan, Wenxin Xu, Wesley Yip, Niki M. Zacharias, Martin H. Voss
Institutions: The University of Texas MD Anderson Cancer Center, Kidney Cancer Association, University of Wisconsin–Madison, Institut Gustave Roussy, University Hospitals Seidman Cancer Center, Case Western Reserve University, Harvard University, Dana-Farber Cancer Institute, Yale Cancer Center, Yale University, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Memorial Sloan Kettering Cancer Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Children's Hospital Colorado, University of Colorado Anschutz, University of Colorado Denver, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, George Washington University, NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, Fox Chase Cancer Center, Kidney Cancer Research Alliance, Exelixis (United States), Brigham and Women's Hospital, Vanderbilt University Medical Center, University of Pittsburgh, Emory University, University of Virginia Health System, Cleveland Clinic, City Of Hope National Medical Center, City of Hope, Vanderbilt-Ingram Cancer Center, University of California, Los Angeles, Ludwig-Maximilians-Universität München, University of Michigan
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: U.S. Department of Defense, V Foundation for Cancer Research, Gateway for Cancer Research, Johnson Foundation, Bristol-Myers Squibb, Kidney Cancer Association, Eli Lilly and Company, Pfizer, Memorial Sloan-Kettering Cancer Center, Regeneron Pharmaceuticals, Exelixis, Jazz Pharmaceuticals, National Comprehensive Cancer Network, UroGen Pharma, Eisai, Astellas Pharma, National Institutes of Health, Genentech, University of Texas MD Anderson Cancer Center, National Cancer Institute, Janssen Pharmaceuticals
Awards: G111615301, G1229558712, G1271809366, G1468253849, G1866298958, G1901027039, G1937241516, G2051006376, G2486300750, G289723095, G293715275, G3988109025, G4102770861, G4550465470, G5024590452, G5659431375, G613936551, G6736661663, G7022711224, G8254662788, G8661970381, G9000003249, G9000034222, G9000067779, Cancer Center Support Grant, G9001170789
OpenAlex ID: W7212444583